Related Articles |
Ovarian cancer-derived extracellular vesicles affect normal human fibroblast behavior.
Cancer Biol Ther. 2018 Mar 26;:1-44
Authors: Giusti I, Francesco MD, Ascenzo S, Palmerini MG, Macchiarelli G, Carta G, Dolo V
Abstract
It has become clear that non-tumor cells in the microenvironment, especially fibroblasts, actively participate in tumor progression. Fibroblasts conditioned by tumor cells become "activated" and, as such, are identified as CAFs (cancer-associated fibroblasts). These CAFs remodel the tumor stroma to make it more favourable for cancer progression. The aim of this work was to verify whether EVs (extracellular vesicles - whose role as mediators of information between tumor and stromal cells is well known) released from human ovarian cancer cells were able to activate fibroblasts. EVs isolated from SKOV3 (more aggressive) and CABA I (less aggressive) cells were administered to fibroblasts. The consequent activation was supported by morphological and molecular changes in treated fibroblasts; XTT assays, zymographies, wound healing tests and invasion assays also highlighted higher proliferation, motility, invasiveness and enzyme expression. The secretome of these "activated" fibroblasts was, in turn, able to modulate the responses (proliferation, motility and invasion) of fibroblasts, and of tumor and endothelial cells. These findings support the idea that ovarian cancer cells can modulate fibroblast behaviour through the release of EVs, activating them to a CAFs-like state; the latter are able, in turn, to stimulate the surrounding cells. EVs from SKOV3 rather than from CABA I seem to be more efficient in some processes.
PMID: 29580188 [PubMed - as supplied by publisher]
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader https://ift.tt/2GBDdbe
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου